Home LiteratureArticle Details
PMID: 6084863 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Modulation of gene expression during terminal cell differentiation: murine erythroleukemia.

Symposium on Fundamental Cancer Research ·Vol. 37 ·1984-00-00 ·Pages 327-40

Marks PA, Murate T, Kaneda T, Ravetch J, Rifkind RA

Abstract

MELC are virus-transformed cells capable of indefinite proliferation that are blocked in differentiation at an early erythroid precursor stage, probably corresponding to CFU-e. A variety of agents, among them HMBA and Me2SO, induce MELC to terminal differentiation and expression of characteristics similar to that associated with normal erythropoiesis. During inducer-mediated terminal differentiation, modulation of expression of a number of genes occurs. Studies to date have characterized inducer-mediated alterations in chromatin structure associated with activation of alpha and beta maj globin genes. Inducer-mediated MELC terminal cell division is also associated with a decrease in the synthesis of the nuclear protein p53, a protein that has been implicated as a requirement for the progression from G1 to S in the cell cycle. HMBA-mediated commitment to terminal cell division is suppressed by steroid. HMBA induces accumulation of mRNAs that may be required for commitment to terminal cell division and whose translation is suppressed by dexamethasone. At least two inducer-activated genes have been identified that may play a role in the transition of terminal cell division.

MeSH Terms
Animals Cell Cycle Cell Differentiation/drug effects Cell Division Chromatin/ultrastructure Erythropoiesis/drug effects Gene Expression Regulation Globins/genetics Interphase Leukemia, Erythroblastic, Acute/genetics,pathology Mice Protein Biosynthesis RNA/biosynthesis Transcription, Genetic
Chemicals
Chromatin RNA Globins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Marks P A
Murate T
Kaneda T
Ravetch J
Rifkind R A
Article Info
Journal
Symposium on Fundamental Cancer Research
Abbr.
Symp Fundam Cancer Res
ISSN
0190-1214
Published
1984-00-00
Pages
327-40
Language
English
Region
United States
NLM ID
100961284
Subset
IM
Grants
NCI NIH HHS · CA08748 · United States
NCI NIH HHS · P01 CA31768-02 · United States
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com